Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Epidermal Growth Factor Receptor Mutation Status: Does Younger Mean More Frequently Mutated?

P W, P K, J CW, K R, K D, B MB, J P, K WK, G C, R R, M S, A G Ph.D, T O, T G, M P, K RŚ, J M.

Balkan J Med Genet. 2017 Dec 29;20(2):89-90. doi: 10.1515/bjmg-2017-0029. eCollection 2017 Dec. No abstract available.

2.

The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions.

Janciauskiene S, Wrenger S, Immenschuh S, Olejnicka B, Greulich T, Welte T, Chorostowska-Wynimko J.

Front Pharmacol. 2018 Apr 17;9:341. doi: 10.3389/fphar.2018.00341. eCollection 2018. Review.

3.

Interleukin 27 in bronchoalveolar lavage fluid in patients with non- small cell lung cancer. Authors' reply.

Kopiński P, Wandtke T, Wędrowska E, Chorostowska-Wynimko J.

Pol Arch Intern Med. 2018 Apr 30;128(4):266-268. doi: 10.20452/pamw.4258. Epub 2018 Apr 27. No abstract available.

4.

SERPINA1 Gene Variants in Granulomatosis with Polyangiitis.

Hadzik-Blaszczyk M, Zdral A, Zielonka TM, Rozy A, Krupa R, Falkowski A, Wardyn KA, Chorostowska-Wynimko J, Zycinska K.

Adv Exp Med Biol. 2018 Feb 20. doi: 10.1007/5584_2018_156. [Epub ahead of print]

PMID:
29460271
5.

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications.

Chapman KR, Chorostowska-Wynimko J, Koczulla AR, Ferrarotti I, McElvaney NG.

Int J Chron Obstruct Pulmon Dis. 2018 Jan 31;13:419-432. doi: 10.2147/COPD.S149429. eCollection 2018. Review.

6.

Pulmonary langerhans cell histiocytosis - insight into the incidence of alfa-1-antitrypsin (A1ATD) deficiency alleles.

Radzikowska E, Struniawski R, Chorostowska-Wynimko J, Wiatr E, Roszkowski-Śliż K.

Adv Respir Med. 2017;85(6):297-300. doi: 10.5603/ARM.2017.0051.

7.

Increased levels of interleukin 27 in patients with early clinical stages of non-small cell lung cancer.

Kopiński P, Wandtke T, Dyczek A, Wędrowska E, Roży A, Senderek T, Przybylski G, Chorostowska-Wynimko J.

Pol Arch Intern Med. 2018 Feb 28;128(2):105-114. doi: 10.20452/pamw.4156. Epub 2017 Nov 29.

8.

Predictors of EGFR mutation and factors associated with clinical tumor stage at diagnosis: Experience of the INSIGHT study in Poland.

Ramlau R, Krawczyk P, Dziadziuszko R, Chmielewska I, Milanowski J, Olszewski W, Stencel K, Ramlau-Piątek K, Segiet A, Skroński M, Grudny J, Chorostowska-Wynimko J.

Oncol Lett. 2017 Nov;14(5):5611-5618. doi: 10.3892/ol.2017.6907. Epub 2017 Sep 7.

9.

Cryptogenic organizing pneumonia-Results of treatment with clarithromycin versus corticosteroids-Observational study.

Radzikowska E, Wiatr E, Langfort R, Bestry I, Skoczylas A, Szczepulska-Wójcik E, Gawryluk D, Rudziński P, Chorostowska-Wynimko J, Roszkowski-Śliż K.

PLoS One. 2017 Sep 25;12(9):e0184739. doi: 10.1371/journal.pone.0184739. eCollection 2017.

10.

Alpha1-antitrypsin binds hemin and prevents oxidative activation of human neutrophils: putative pathophysiological significance.

Janciauskiene S, Tumpara S, Wiese M, Wrenger S, Vijayan V, Gueler F, Chen R, Madyaningrana K, Mahadeva R, Welte T, Immenschuh S, Chorostowska-Wynimko J.

J Leukoc Biol. 2017 Oct;102(4):1127-1141. doi: 10.1189/jlb.3A0317-124R. Epub 2017 Jul 17.

PMID:
28716864
11.

Quantitative disease progression model of α-1 proteinase inhibitor therapy on computed tomography lung density in patients with α-1 antitrypsin deficiency.

Tortorici MA, Rogers JA, Vit O, Bexon M, Sandhaus RA, Burdon J, Chorostowska-Wynimko J, Thompson P, Stocks J, McElvaney NG, Chapman KR, Edelman JM.

Br J Clin Pharmacol. 2017 Nov;83(11):2386-2397. doi: 10.1111/bcp.13358. Epub 2017 Aug 11.

12.

Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?

Carleo A, Chorostowska-Wynimko J, Koeck T, Mischak H, Czajkowska-Malinowska M, Rozy A, Welte T, Janciauskiene S.

Int J Chron Obstruct Pulmon Dis. 2017 Mar 8;12:829-837. doi: 10.2147/COPD.S125240. eCollection 2017.

13.

miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives.

Florczuk M, Szpechcinski A, Chorostowska-Wynimko J.

Target Oncol. 2017 Apr;12(2):179-200. doi: 10.1007/s11523-017-0478-5. Review.

PMID:
28243959
14.

Clarithromycin Decreases IL-6 Concentration in Serum and BAL Fluid in Patients with Cryptogenic Organizing Pneumonia.

Radzikowska E, Roży A, Jagus P, Polubiec-Kownacka M, Wiatr E, Chorostowska-Wynimko J, Roszkowski-Śliż K.

Adv Clin Exp Med. 2016 Sep-Oct;25(5):871-878. doi: 10.17219/acem/61953.

15.

Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE).

McElvaney NG, Burdon J, Holmes M, Glanville A, Wark PA, Thompson PJ, Hernandez P, Chlumsky J, Teschler H, Ficker JH, Seersholm N, Altraja A, Mäkitaro R, Chorostowska-Wynimko J, Sanak M, Stoicescu PI, Piitulainen E, Vit O, Wencker M, Tortorici MA, Fries M, Edelman JM, Chapman KR; RAPID Extension Trial Group.

Lancet Respir Med. 2017 Jan;5(1):51-60. doi: 10.1016/S2213-2600(16)30430-1. Epub 2016 Dec 2. Erratum in: Lancet Respir Med. 2017 Feb;5(2):e13.

PMID:
27916480
16.

Standards for diagnosis and care of patients with inherited alpha-1 antitrypsin deficiency Recommendations of the Polish Respiratory Society, Polish Society of Pediatric Pulmonology and Polish Society of Pediatric Gastroenterology.

Chorostowska-Wynimko J, Bakuła A, Kulus M, Kuca P, Niżankowska-Mogilnicka E, Sanak M, Socha P, Śliwiński P.

Pneumonol Alergol Pol. 2016;84(3):193-202. doi: 10.5603/PiAP.2016.0023. No abstract available.

17.

Disease Modification in Emphysema Related to Alpha-1 Antitrypsin Deficiency.

Chorostowska-Wynimko J.

COPD. 2016 Dec;13(6):807-815. Epub 2016 May 12. Review.

PMID:
27172295
18.

Effectiveness of PCR and Immunofluorescence Techniques for Detecting Human Cytomegalovirus in Blood and Bronchoalveolar Lavage Fluid.

Roży A, Duk K, Szumna B, Skrońska P, Gawryluk D, Chorostowska-Wynimko J.

Adv Exp Med Biol. 2016;921:21-6. doi: 10.1007/5584_2016_246.

PMID:
27161108
19.

Frequency of Rare Alpha-1 Antitrypsin Variants in Polish Patients with Chronic Respiratory Disorders.

Duk K, Zdral A, Szumna B, Roży A, Chorostowska-Wynimko J.

Adv Exp Med Biol. 2016;910:47-53. doi: 10.1007/5584_2016_213.

PMID:
26987331
20.

Cryptogenic Organizing Pneumonia: IL-1β, IL-6, IL-8, and TGF- β1 Serum Concentrations and Response to Clarithromycin Treatment.

Radzikowska E, Roży A, Jaguś P, Wiatr E, Gawryluk D, Chorostowska-Wynimko J, Roszkowski-Śliż K.

Adv Exp Med Biol. 2016;911:77-85. doi: 10.1007/5584_2016_223.

PMID:
26987326
21.

Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone.

Stempel DA, Raphiou IH, Kral KM, Yeakey AM, Emmett AH, Prazma CM, Buaron KS, Pascoe SJ; AUSTRI Investigators.

N Engl J Med. 2016 May 12;374(19):1822-30. doi: 10.1056/NEJMoa1511049. Epub 2016 Mar 6.

22.

Plasma cell-free DNA levels and integrity in patients with chest radiological findings: NSCLC versus benign lung nodules.

Szpechcinski A, Rudzinski P, Kupis W, Langfort R, Orlowski T, Chorostowska-Wynimko J.

Cancer Lett. 2016 May 1;374(2):202-7. doi: 10.1016/j.canlet.2016.02.002. Epub 2016 Feb 5.

PMID:
26854716
23.

[Programmed necrosis and necroptosis - molecular mechanisms].

Giżycka A, Chorostowska-Wynimko J.

Postepy Hig Med Dosw (Online). 2015 Dec 16;69:1353-63. Review. Polish.

24.

Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene Therapy.

Wozniak J, Wandtke T, Kopinski P, Chorostowska-Wynimko J.

Hum Gene Ther. 2015 Nov;26(11):709-18. doi: 10.1089/hum.2015.044. Epub 2015 Sep 29. Review.

25.

Coexistence of Borrelia burgdorferi s.l. genospecies within Ixodes ricinus ticks from central and eastern Poland.

Sytykiewicz H, Karbowiak G, Chorostowska-Wynimko J, Szpechciński A, Supergan-Marwicz M, Horbowicz M, Szwed M, Czerniewicz P, Sprawka I.

Acta Parasitol. 2015 Dec;60(4):654-61. doi: 10.1515/ap-2015-0093.

PMID:
26408587
26.

Correlation of serum vascular endothelial growth factor-D concentration with clinical presentation and course of lymphangioleiomyomatosis.

Radzikowska E, Jaguś P, Sobiecka M, Chorostowska-Wynimko J, Wiatr E, Kuś J, Roszkowski-Śliż K.

Respir Med. 2015 Nov;109(11):1469-75. doi: 10.1016/j.rmed.2015.09.005. Epub 2015 Sep 12.

27.

How Can We Improve the Detection of Alpha1-Antitrypsin Deficiency?

Ferrarotti I, Poplawska-Wisniewska B, Trevisan MT, Koepke J, Dresel M, Koczulla R, Ottaviani S, Baldo R, Gorrini M, Sala G, Cavallon L, Welte T, Chorostowska-Wynimko J, Luisetti M, Janciauskiene S.

PLoS One. 2015 Aug 13;10(8):e0135316. doi: 10.1371/journal.pone.0135316. eCollection 2015.

28.

The Effect of Incidental Consolidation on Management and Outcomes in COPD Exacerbations: Data from the European COPD Audit.

Saleh A, López-Campos JL, Hartl S, Pozo-Rodríguez F, Roberts CM; European COPD Audit team.

PLoS One. 2015 Jul 27;10(7):e0134004. doi: 10.1371/journal.pone.0134004. eCollection 2015.

29.

Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease.

Szpechcinski A, Chorostowska-Wynimko J, Struniawski R, Kupis W, Rudzinski P, Langfort R, Puscinska E, Bielen P, Sliwinski P, Orlowski T.

Br J Cancer. 2015 Jul 28;113(3):476-83. doi: 10.1038/bjc.2015.225. Epub 2015 Jun 30.

30.

The national alpha-1 antitrypsin deficiency registry in Poland.

Chorostowska-Wynimko J, Struniawski R, Sliwinski P, Wajda B, Czajkowska-Malinowska M.

COPD. 2015 May;12 Suppl 1:22-6. doi: 10.3109/15412555.2015.1021915.

PMID:
25938287
31.

Lung cancer: our blood, sweat and fears.

Chorostowska-Wynimko J.

Pneumonol Alergol Pol. 2015;83(2):98-100. doi: 10.5603/PiAP.2015.0016. No abstract available.

32.

Targeted screening programmes in COPD: how to identify individuals with α1-antitrypsin deficiency.

Chorostowska-Wynimko J.

Eur Respir Rev. 2015 Mar;24(135):40-5. doi: 10.1183/09059180.00010614. Review.

33.

Studies of hepatocyte growth factor in bronchoalveolar lavage fluid in chronic interstitial lung diseases.

Przybylski G, Chorostowska-Wynimko J, Dyczek A, Wędrowska E, Jankowski M, Szpechciński A, Giżycka A, Golińska J, Kopiński P.

Pol Arch Med Wewn. 2015;125(4):260-71. Epub 2015 Feb 20. Erratum in: Pol Arch Med Wewn. 2015;125(6):482-3.

34.

Alpha-1 antitrypsin deficiency, SZ phenotype: a rare type of a rare disease. Case report.

Nebunoiu AM, Deleanu OC, Rohan I, Mihălţan F, Chorostowska-Wynimko J, Ulmeanu R.

Pneumologia. 2014 Oct-Dec;63(4):218-23.

PMID:
25665366
35.

[Programmed cell death: is it only apoptosis?].

Kopiński P, Gizycka A, Chorostowska-Wynimko J.

Pol Merkur Lekarski. 2014 Oct;37(220):201-5. Polish.

PMID:
25518573
36.

Methodological recommendations for the diagnostics of EGFR gene mutations and ALK gene rearrangement in the selection of non-small-cell lung cancer patients to molecularly targeted therapies.

Krawczyk P, Chorostowska-Wynimko J, Dziadziuszko R, Jassem J, Krzakowski M, Langfort R, Puacz E, Wasąg B, Wojas-Krawczyk K.

Pneumonol Alergol Pol. 2014;82(5):437-44. doi: 10.5603/PiAP.2014.0057.

37.

The efficacy of EGFR gene mutation testing in various samples from non-small cell lung cancer patients: a multicenter retrospective study.

Krawczyk P, Ramlau R, Chorostowska-Wynimko J, Powrózek T, Lewandowska MA, Limon J, Wasąg B, Pankowski J, Kozielski J, Kalinka-Warzocha E, Szczęsna A, Wojas-Krawczyk K, Skroński M, Dziadziuszko R, Jaguś P, Antoszewska E, Szumiło J, Jarosz B, Woźniak A, Jóźwicki W, Dyszkiewicz W, Pasieka-Lis M, Kowalski DM, Krzakowski M, Jassem J, Milanowski J.

J Cancer Res Clin Oncol. 2015 Jan;141(1):61-8. doi: 10.1007/s00432-014-1789-x. Epub 2014 Aug 3.

38.

[Current methods to detect EGFR gene mutations as predictive factor for targeted therapies in non-small cell lung cancer - is there a "golden standard" in diagnostics?].

Skroński M, Szpechciński A, Chorostowska-Wynimko J.

Pneumonol Alergol Pol. 2014;82(3):311-22. doi: 10.5603/PiAP.2014.0036. Review. Polish.

39.

[Apoptosis of alveolar lymphocytes. Part 1: pathways of lymphocyte apoptosis].

Kopiński P, Chorostowska-Wynimko J, Dyczek A, Giżycka A.

Pneumonol Alergol Pol. 2014;82(2):170-82. doi: 10.5603/PiAP.2014.0023. Review. Polish.

40.

[The role of systemic therapies of non-small cell lung cancer and malignant pleural mesothelioma: updated expert recommendations].

Jassem J, Biernat W, Bryl M, Chorostowska-Wynimko J, Dziadziuszko R, Krawczyk P, Kordek R, Kowalski DM, Krzakowski M, Olszewski W, Orłowski T, Ramlau R, Rzyman W.

Pneumonol Alergol Pol. 2014;82(2):133-49. doi: 10.5603/PiAP.2014.0019. Review. Polish.

41.

Role of serum vascular endothelial growth factor D in discrimination of patients with polycystic lung diseases.

Radzikowska E, Jaguś P, Skoczylas A, Sobiecka M, Chorostowska-Wynimko J, Wiatr E, Kuś J, Roszkowski-Śliż K.

Pol Arch Med Wewn. 2013;123(10):533-8. Epub 2013 Sep 24.

42.

Variability of hospital resources for acute care of COPD patients: the European COPD Audit.

López-Campos JL, Hartl S, Pozo-Rodriguez F, Roberts CM; European COPD Audit team.

Eur Respir J. 2014 Mar;43(3):754-62. doi: 10.1183/09031936.00074413. Epub 2013 Aug 29.

43.

[Believe in miracles--Central-Eastern European Alpha-1 Antitrypsin Network].

Chorostowska-Wynimko J.

Pneumonol Alergol Pol. 2013;81(4):285-7. Polish. No abstract available.

44.

Incidence of alpha-1 antitrypsin Z and S alleles in patients with granulomatosis with polyangiitis--pilot study.

Chorostowska-Wynimko J, Gawryluk D, Struniawski R, Popławska B, Fijołek J.

Pneumonol Alergol Pol. 2013;81(4):319-22.

45.

European hospital adherence to GOLD recommendations for chronic obstructive pulmonary disease (COPD) exacerbation admissions.

Roberts CM, Lopez-Campos JL, Pozo-Rodriguez F, Hartl S; European COPD Audit team.

Thorax. 2013 Dec;68(12):1169-71. doi: 10.1136/thoraxjnl-2013-203465. Epub 2013 Jun 1.

PMID:
23729193
46.

[Higher incidence of alveolar lymphocytes (AL) apoptosis in smokers depends on BCL-2 expression and specific response to tumor necrosis factor alpha (TNFalpha). Bronchoalveolar lavage (BAL) material analysis from selected interstitial lung diseases (ILD) and healthy controls].

Kopiński P, Dyczek A, Chorostowska-Wynimko J, Marszałek A, Balicka-Slusarczyk B, Kubiszewska I, Szabłowska K, Półgesek E, Szpechciński A.

Przegl Lek. 2012;69(10):731-6. Polish.

PMID:
23421021
47.

[Advances in pulmonology in year 2012].

Chorostowska-Wynimko J, Demkow U, Górski P, Krenke K, Kurzyna M, Kuś J, Langfort R, Maszkowska-Kopij K, Roszkowski-Śliż K, Skorupa W, Sobczyńska-Tomaszewska A, Szołkowska M, Torbicki A.

Pneumonol Alergol Pol. 2013;81(2):162-81. Polish. No abstract available.

48.

[Genetic variants of alpha-1 antitrypsin: classification and clinical implications].

Popławska B, Janciauskiene S, Chorostowska-Wynimko J.

Pneumonol Alergol Pol. 2013;81(1):45-54. Review. Polish.

49.

Heterozygous α1‑antitrypsin deficiency in liver transplant candidates.

Górska K, Korczyński P, Struniawski R, Krenke R, Ołdakowska-Jedynak U, Grabczak EM, Klimiuk J, Chorostowska-Wynimko J, Chazan R, Zieliński J, Krawczyk M.

Pol Arch Med Wewn. 2013;123(1-2):14-20. Epub 2012 Dec 11.

50.

[EUROPEAN COPD AUDIT in Poland--how do we treat the patients with COPD exacerbation?].

Chorostowska-Wynimko J, Górecka D, Sliwiński P, Roszkowski-Śliż K.

Pneumonol Alergol Pol. 2012;80(6):493-7. Polish. No abstract available.

Supplemental Content

Loading ...
Support Center